Synapse - Hematologic Malignancies Research

Results (3005)

A phase 2 single-center study of carfilzomib 56 mg/m2 with or without low-dose dexamethasone in relapsed multiple myeloma

Journal Article

Lendvai, N.; Hilden, P.; Devlin, S.; Landau, H.; Hassoun, H.; Lesokhin, A. M.; Tsakos, I.; Redling, K.; Koehne, G.; Chung, D. J.; more...
Blood (2014)

Fulltext@MSK | Save

Reduction in H3k27me3 is a molecular and prognostic surrogate in pediatric glioblastomas

Meeting Abstract

Venneti, S.; Santi, M.; Felicella, M. M.; Sullivan, L. M.; Dolgalev, I.; Martinez, D.; Perry, A.; Lewis, P. W.; Allis, D. C.; Thompson, C. B.; more...
Neuro-Oncology (2014)

Fulltext@MSK | Save

Development of inducible switch promoters that drive exogenous gene expression upon the recognition of CD19 by chimeric antigen receptors

Meeting Abstract

Uchibori, R.; Ninomiya, S.; Tsukahara, T.; Ido, H.; Teruya, T.; Omine, K.; Urabe, M.; Mizukami, H.; Kume, A.; Riviere, I.; more...
Molecular Therapy (2014)

Fulltext@MSK | Save

Tol2 transposon system mediates stable gene transfer of CD19-specific chimeric antigen receptor to primary human T-cells for the treatment of B-cell malignancies

Meeting Abstract

Tsukahara, T.; Iwase, N.; Yamamoto, C.; Ohmine, K.; Uchibori, R.; Teruya, T.; Ido, H.; Urabe, M.; Mizukami, H.; Kume, A.; more...
Molecular Therapy (2014)

Fulltext@MSK | Save

Blocking CD47 improves CAR T cell therapy

Meeting Abstract

Pegram, H. J.; Purdon, T. J.; Brentjens, R. J.
Molecular Therapy (2014)

Fulltext@MSK | Save

beta-Globin gene editing in human cells using TALENs and ssDNA oligonucleotides: Towards a gene repair approach for sickle cell anemia and beta-thalassemias